10x Genomics (TXG) Interest Expenses (2018 - 2026)

10x Genomics (TXG) has 9 years of Interest Expenses data on file, last reported at $17.4 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses fell 82.14% year-over-year to $17.4 million; the trailing twelve-month figure through Mar 2026 stood at $17.4 million (down 82.14% YoY), and the FY2025 full-year result was $490.2 million, up 2.23% from the prior year.
• Interest Expenses improved to $17.4 million in Q1 2026, from $16.2 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $130.0 million in Q1 2023 to a low of $11.7 million in Q4 2022.
• A 5-year average of $59.0 million and a median of $26.5 million in 2023 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses surged 1013.11% in 2022 and slumped 82.14% in 2026, its largest moves.
• Tracing TXG's Interest Expenses over 5 years: stood at $11.7 million in 2022, then gained by 25.66% to $14.8 million in 2023, then advanced by 20.54% to $17.8 million in 2024, then slipped by 8.97% to $16.2 million in 2025, then grew by 7.48% to $17.4 million in 2026.
• Business Quant data shows TXG's Interest Expenses at $17.4 million in Q1 2026, $16.2 million in Q4 2025, and $106.9 million in Q3 2025.